Vioxx

• Study Links Common Painkillers to Heart Failure
• Merck Hopes New Study Will Help In Vioxx Defense
• Study Finds Vioxx Dangers Occur Earlier Than Expected
• Jury Awards $9 Million In Punitive Vioxx Damages
• Merck Acquitted In New Jersey Vioxx Case
• FDA Refuses to Approve Pfizer Cox-2 Drug
• Class Action Could Cost Merck Billions
• Merck Could Get Hit Even Harder In Next Vioxx Suits

• Jury Finds Merck Liable in First Vioxx Trial
• Judge Approves Vioxx Class Action
• Canada May Allow Resumption Of Vioxx Sales
• Texas Sues Merck For Downplaying Dangers Of Vioxx
• Study Links Ibuprofen, Other Pain Relievers To Heart Risk
• Study: Iboprofen May Reduce Heart Risks
• Congress Probes Merck's Vioxx Sales Tactics
• Vioxx Judge Orders Settlement Talks
• Tempers Flare as Vioxx Cases Come to Trial
• FDA Asks Pfizer to Withdraw Bextra
• FDA Panel Members Indebted to Drug Companies
• FDA Panel Recommends Vioxx Be Allowed to Return
• Vioxx May Have Caused 140,000 Heart Attacks
• States Win Expansion Of Vioxx Refunds
• Vioxx Critic to Publish Report
• States Win Expansion of Vioxx Refund Program
• Study Finds Celebrex Safer Than Vioxx
• FDA Vet Blows Whistle on "Broken" Agency
• Bextra Doubles Risk of Heart Attack and Stroke, Study Finds
• Merck Faces Criminal Probe in Vioxx Case
• FDA Estimates Vioxx Caused 27,785 Deaths
• Merck Knew of Vioxx Dangers, Report Charges
• Vioxx Pain Worsens for Doctors, Patients, Drug Companies
• States Question Vioxx Refund Process
• Class Actions Galore After Vioxx Withdrawal
• Canadians File Vioxx Class Action
• Merck Withdraws Vioxx
• Consumer Complaints